Skip to main content
. 2024 Jul 25;12(9):e00641-24. doi: 10.1128/spectrum.00641-24

TABLE 1.

Patient HPgV-1 sequencing contig and coverage parameters

Patient ID HCV treatment outcome Genotype Length of contig Coverage of genome (%) Average depth GenBank accession no.
A102 SVR 2 9,367 99.7 8,138 PP783765
A103 SVR 2 9,380 99.9 144,268 PP783766
A106 Failure 1 9,386 99.9 171,647 PP783767
A112 SVR 2 9,395 99.9 268,890 PP783768
A117 Failure 2 9,383 99.9 245,100 PP783769
A119 Failure 1 9,386 99.9 66,103 PP783770
A123 SVR 2 9,391 99.9 186,664 PP783771
A124 Failure 2 9,383 99.9 140,452 PP783772
A125 Failure 2 9,386 99.9 174,703 PP783773
A126 SVR 2 9,387 99.9 357,073 PP783774
W101 SVR 2 9,204 98.0 617 PP783778
W108 SVR 2 9,228 98.2 5,820 PP783779
W130 SVR 2 8,664 92.7 2,410 PP783780
W133 SVR 2 8,929 95.1 5,576 PP783781
W136 Failure 2 9,384 99.9 45,367 PP783782
W143 SVR 2 9,371 99.8 12,361 PP783783
W145 SVR 2 9,378 99.8 33,304 PP783784
T134 SVR 2 9,345 99.5 13,057 PP783775
T167 SVR 2 9,376 99.8 12,998 PP783776
T213 SVR 2 9,362 99.7 27,432 PP783777